Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + Raltitrexed in 2nd Line Colorectal Cancer
NCT00234429Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in colorectal carcinoma (CRC), sponsored by AstraZeneca. Started Nov 2003; status: completed.
02
Drugs
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT00234429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234429.